Our Platform

Desarrollamos, producimos y comercializamos kits de diagnóstico molecular para enfermedades hereditarias, infecciosas y farmacogenómica de drogas

IRIS Genomic platform.

IRIS is a medium-throughput genomics platform based on microarray technology which allows the molecular diagnostic of hereditary diseases, infectious diseases and pharmacogenomics of drugs


In emerging countries, the access to molecular diagnostic is limited because the most of available technology have been developed in accordance with the characteristics of healthcare systems in advanced countries, which implies certain difficulties for laboratories:

High level of investment in equipment

Expensive consumables

Lack of local technical assistance

High number of samples for each use of the equipment

Demanding requirements of facilities

Requirements of highly qualified personnel


The IRIS Platform has been designed in accordance with the characteristics of healthcare systems in emerging countries, presenting several advantages that, in general, simplify the implementation and make it adaptable to any laboratory:

Modular equipment and low investment

Consumables at lower cost


Low number of samples for each use of the equipment

Versatile, many trials can be realized at once

Adaptable fácilmente al workflow de cualquier laboratorio

Easily adaptable to the workflow of any laboratory

Safe and reliable results

IRIS Platform benefits.


The IRIS Platform uses basic molecular biology equipment, adding only two inexpensive and modular equipment, of easy maintenance and with local technical support.

Fácil operatividad

The IRIS Platform can be operated by technical staff with basic training on molecular biology. Our software analyses the data automatically without the need of specialized personnel.

Resultados seguros y confiables

The platform comprises 7 internal controls for each sample, which allow assessing the quality of each procedure. The algorithm of IRIS software analyzes the controls status before offering the result.

Baja escala mínima

IRIS requires a smaller number of samples for each equipment use: 15 samples rather than 96 or 384. Thus, the laboratories do not need to accumulate samples to conduct the analysis and speed time to results.


The procedure and microarrays are the same for all tests of the IRIS portfolio. Thus, the IRIS Platform allows to analyze the desired test for each sample, independently whatever the test to analyze in the remaining samples. This simplifies even more sampling for the laboratory.


It is easily and economically tailored to number of samples for processing per day by the laboratory.

Estas ventajas permiten una fácil y económica implementación de la Plataforma IRIS, lo que ofrece la posibilidad de la descentralización del diagnóstico molecular a cualquier laboratorio o centro de salud tanto público como privado, de un país emergente.

IRIS platform process.

Duration times of each stage of the molecular diagnostic process using the IRIS Platform,

1h 30'

DNA Sample + Reagents A

PCR amplification


PCR product + Reagents G

PCR Genotyping

1h 30'

PCR product + Reagents H

Hybridization in Microarray


Microarray + Washing solutions

Scanning of the microarray


IRIS software image analysis

Results report